Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtronic Growth Plan: Boost R&D Productivity, Globalization

This article was originally published in PharmAsia News

Executive Summary

Medtronic's growth acceleration plan calls for optimizing its research and development investments, accelerating globalization efforts, and improving execution of all initiatives, according to newly installed CEO Omar Ishrak

You may also be interested in...

Medtronic Banks On China For R&D; Plans To Hire 1,000 Staff For New Shanghai Center

Medtronic’s Shanghai Innovation Center is the company’s first in Asia and the first outside the U.S. or Europe.

Medtronic Aims To Double Its Presence In Emerging Markets By 2015-2016

In its first in-depth investor meeting in two years, Medtronic emphasized emerging markets, its ability to demonstrate economic worth, broad product offerings and pipeline as keys to growth.

Emerging Views On Emerging Markets: JP Morgan Healthcare Conference (Part 1 of 2)

Emerging markets continued to play a large role in company presentations during the industry’s largest investor conference. PharmAsia News takes a closer look.

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts